乳腺增生诊治临床实践指南2021.V1(CSBrS-Guideline-03)

标题: 乳腺增生诊治临床实践指南2021.V1(CSBrS-Guideline-03)
title: Clinical practice guideline for diagnosis and treatment of hyperplasia of the mammary glands: Chinese Society of Breast Surgery practice guidelines 2021
版本: 原创版
version: Original
分类: 标准指南
classification: Standard guideline
领域: 诊疗
field: Diagnosis and Treatment
国家和地区: 中国
Country and region: China
指南使用者:
Guide users:
证据分级方法: Table 1 Standard of level of evidence Level of evidence Standard I Based on high-level prospective randomized controlled clinical trials, observational studies or meta-analyses with large sample sizes, internationally-recognized current guidelines and consensus statements, published guidelines and consensus statements from national societies or associations, Chinese population-based studies of the above types published in SCI journals, MEDLINE journals, and Chinese series journals II Based on low-level randomized clinical trials, well-designed non-controlled trials or cohort studies, inter-continental professional association guidelines and international conference expert consensus statements, published guidelines and consensus statements from national regional societies or associations, Chinese population-based studies of the above types published in PKU core journals III Based on case-control studies or retrospective studies, published guidelines and consensus statements from national professional associations, and provincial societies or associations, Chinese population-based studies of the above types published in source journals for Chinese scientific and technical papers and citations IV Based on case reports, scientific hypotheses, regional expert consensus statements and published guidelines and consensus statements from national local societies or associations, Chinese population-based studies of the above types published in non-aforementioned core journals
Evidence grading method:
制定单位: 中华医学会外科学分会乳腺外科学组
Formulating unit: The Chinese Society of Breast Surgery
注册时间: 2021-07-10
Registration time:
注册编号: IPGRP-2021CN191
Registration number:
指南制订的目的:
Purpose of the guideline: